PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Plexus Ventures, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Plexus Ventures Announces Assignment from U.S Pharmacia Participation in BIO 2008 - Plexus Ventures announces a new assignment from US Pharmacia and Participation in the BIO 2008 International Conference
Plexus Ventures Announces Assignment from U.S Pharmacia Participation in BIO 2008

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/05/21 - Plexus Ventures announces a new assignment from US Pharmacia and Participation in the BIO 2008 International Conference.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Plexus Ventures is pleased to announce its appointment by US Pharmacia (Warsaw, Poland) to augment the company's internal resources by providing additional business development services.

Michael O'Sullivan, Managing Director of Plexus Ventures, commented: "With 12 seasoned business development professionals in nine cities worldwide, Plexus Ventures is well-positioned to help US Pharmacia, Poland's leading OTC company, to achieve its growth objectives."

About US Pharmacia

US Pharmacia is the leading OTC company in the Polish market and ranks as the 5th largest OTC company in Europe. US Pharmacia markets well-known consumer brands in the analgesic, cough/cold, GI, allergy and vitamin categories.

Plexus Ventures Chairs Japan Business Development Session at BIO 2008

Plexus Ventures, a leading business development consultancy specializing in pharmaceuticals and biotechnology transactions, announced today that Richard A. Brown, General Partner and Head of Tokyo Office will chair a breakout session at the 2008 BIO International Convention. The session is titled "Not Lost in Translation: Successfully Forging Japanese Pharma and Western Biotech Collaborations" and is part of the "Doing Business Globally" track at the conference taking place June 17-20, 2008 in San Diego, CA.

Mr. Brown's workshop includes speakers from both Western and Japanese companies who have entered into such collaborations, who will discuss practical considerations and funding advantages of working with a Japanese partner, the Japanese business model, deal-making strategies and cultural considerations. Through presentations from four speakers, business development executives and others involved in the deal-making process will hear the perspectives of both sides of these East-West collaborations, and how one manages the entire deal process, from relationship-building, negotiating, structuring the deal, and implementing the collaboration.

Confirmed participants for the June 17, 2008 session are: Jeffrey Abbey, Vice President, Business Development, Argos Therapeutics; Pär Gellerfors, Ph.D., Chief Executive Officer, BioArctic Neuroscience AB; Hideki Hayashi, Senior Vice President, Corporate Business Development, Eisai Co., Ltd.; and Tamao Watanabe, Senior Manager of Business Development, Kirin Pharma Company Limited;

Plexus Ventures' Tokyo office assists Japanese companies to establish and grow their presence outside Japan and Western companies who wish to partner their assets with Japanese. Mr. Brown is active in the Japanese business development community, is a member of PharmaDelegates and the Japanese Pharmaceutical Licensing Association, and has been a regular guest lecturer at the Business Development Training Seminars conducted by Yamasaki Pharma Consulting in Tokyo and Osaka.

"Not Lost in Translation: Successfully Forging Japanese Pharma and Western Biotech Collaborations" takes place on Tuesday June 17, 2008 from 8:15 - 9:45 AM as part of the 2008 BIO International Convention at San Diego Convention Center. In addition to Mr. Brown, Mr. Pino Modica, Managing Partner of Plexus Ventures will be in attendance throughout the BIO Convention. To inquire about meeting availability, please e-mail mas[.]plexusventures.com.

About Plexus Ventures

Plexus Ventures (plexusventures.com), founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Frankfurt, Indianapolis, London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Plexus Ventures, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Plexus Ventures Announces Assignment from U.S Pharmacia Participation in BIO 2008

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mary Alice Strong - PlexusVentures.com 
310-315-7106 maryalice_strong[.]plexusventures.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Plexus Ventures, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Plexus Ventures, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)